Nura Bio
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
171 Oyster Point Blvd Ste 401, South San...Website
www.nurabio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
1
About Nura Bio
Nura Bio, Inc. (Nura Bio) is a clinical-stage biopharmaceutical company developing neuroprotective therapies for the treatment of a broad range of neurological diseases. Nura Bio’s research and early development small molecule pipeline is focused on developing therapies that halt axon degeneration and/or modulate microglial responses to degeneration and injury, with the goal of conferring neuroprotection across diseases of the central, peripheral, and ocular nervous systems.Explore more
Nura Bio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nura Bio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Nura Bio launches new products
Click to see if Nura Bio had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Nura Bio
Check out if Nura Bio is spiking on competitors!
Nura Bio, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Nura Bio recently announced quarterly report
Check if Nura Bio has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Nura Bio has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Nura Bio
Compare insights from companies similar to Nura Bio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nura Bio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Nura Bio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Nura Bio.
Nura Bio financials insights
Gather financial insights about Nura Bio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$140M
2026
Series B
$73.8M
Nura Bio Tech Stack
A closer look at the technologies used by Nura Bio
See more technologies
Most Recent Scoops
Funding
Funding
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
, according to a front-line source in DevOps, has completed initiatives related to communication and collaboration within the last nine months.
Collaboration/Web Apps, DevOps, Employee Relations, Unified Communications, Communications
Project
Request for Proposal (RFP), DevOps, Workforce Management
Nura Bio News & Media
Mehta named CMO, Greenberg CBO at Nura Bio - BioCentury
Neurological diseases company Nura Bio Inc. named Lahar Mehta CMO and Scott Greenberg CBO. Mehta was SVP, head of global clinical development at Amyl...Nura Bio Expands Leadership Team with C-Suite Appointments
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nura Bio, Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small molecule therapies for the treatment of debilitating neurological diseases, announced today the appointments of Lahar Mehta, M.D. as Chief Medical Officer, and Scott Greenberg as Chief Business Officer. Dr. Mehta and Mr. Greenberg will play key roles as Nura Bio builds a clinical pipeline across a broad range of neurological diseases. “At Nura BiNura Bio Closes Series A Financing with $68 Million in New Funds, Bringing Total Raised to $140+ Million
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nura Bio Inc. (Nura Bio), a clinical-stage, biopharmaceutical company developing neuroprotective, small molecule therapies for the treatment of debilitating neurological diseases, announced today the closing of more than $140 million in Series A financing. This includes the addition of $68 million to the initial Series A round of $73 million which was announced in 2020. The round was led by founding investor The Column Group, with participation fromNura Bio Initiates Phase I Clinical Trial for its Oral, Brain-Penetrant SARM1 Inhibitor, NB-4746
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Nura Bio, Inc. (Nura Bio), a biopharmaceutical company developing neuroprotective, small molecule therapies for the treatment of debilitating neurological diseases, today announced the initiation of the Phase 1 clinical trial of its SARM1 inhibitor, NB-4746. NB-4746 is believed to be a first-in-class, oral, brain-penetrant, neuroprotective SARM1 inhibitor with broad therapeutic potential across diseases of the central, peripheral, and ocular nervous
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Nura Bio
Sign Up For FreeTo access detailed company insights
Nura Bio, Inc. (Nura Bio) is a clinical-stage biopharmaceutical company developing neuroprotective therapies for the treatment of a broad range of neurological diseases. Nura Bio’s research and early development small molecule pipeline is focused on developing therapies that halt axon degeneration and/or modulate microglial responses to degeneratio... Read More
